OSAIC HOLDINGS, INC. - HUMACYTE INC ownership

HUMACYTE INC's ticker is and the CUSIP is 44486Q103. A total of 72 filers reported holding HUMACYTE INC in Q3 2022. The put-call ratio across all filers is 0.96 and the average weighting 0.0%.

Quarter-by-quarter ownership
OSAIC HOLDINGS, INC. ownership history of HUMACYTE INC
ValueSharesWeighting
Q3 2023$116,015
+19.4%
39,600
+16.5%
0.00%
Q2 2023$97,203
+7.5%
33,985
+16.3%
0.00%
Q1 2023$90,414
+55.9%
29,210
+5.3%
0.00%
Q4 2022$58,000
-34.1%
27,729
+3.1%
0.00%
Q3 2022$88,000
+2.3%
26,904
+0.2%
0.00%
Q2 2022$86,000
-51.4%
26,854
+7.3%
0.00%
Q1 2022$177,000
+21.2%
25,020
+24.6%
0.00%
Q4 2021$146,000
-30.8%
20,074
+10.2%
0.00%
Q3 2021$211,00018,2240.00%
Other shareholders
HUMACYTE INC shareholders Q3 2022
NameSharesValueWeighting ↓
York Capital Management Global Advisors, LLC 2,291,397$16,613,0003.70%
Monashee Investment Management LLC 399,910$2,899,0000.72%
Endowment Wealth Management, Inc. 96,618$700,0000.71%
Gladstone Institutional Advisory LLC 246,717$1,7890.14%
Diameter Capital Partners LP 300,338$2,177,0000.13%
CenterBook Partners LP 23,706$172,0000.10%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 900,100$6,526,000,0000.06%
Exos Asset Management LLC 16,139$117,0000.06%
Maven Securities LTD 200,000$1,450,0000.04%
VALLEY FORGE INVESTMENT CONSULTANTS INC ADV 11,000$80,0000.04%
View complete list of HUMACYTE INC shareholders